Nasdaq Verafin and BioCatch Partner to Combat Payments Fraud with Advanced Technology.

Nasdaq Verafin and BioCatch have formed a strategic partnership to combat payments fraud. The alliance combines Verafin's fraud detection platform and consortium data network with BioCatch's behavioral and device intelligence. This partnership aims to address the growing problem of payments fraud, which accounted for the majority of the estimated $486 billion in global fraud losses in 2023.

New York (Sept. 3, 2025) — Nasdaq Verafin and BioCatch have announced a strategic partnership aimed at bolstering financial institutions' defenses against payments fraud. The alliance leverages Verafin's fraud detection platform and consortium data network with BioCatch's behavioral and device intelligence to address the growing challenge of payments fraud, which accounted for the majority of the estimated $486 billion in global fraud losses in 2023 [1].

The initial phase of the partnership will integrate BioCatch alerts and insights into the Nasdaq Verafin platform, transforming fraud prevention efforts. This integration empowers financial institutions to take pre-emptive action against fraudulent transactions by using both behavioral and transactional intelligence. By combining these powerful solutions, the partnership equips financial institutions with holistic risk insights and real-time decision-making capabilities [1].

Stephanie Champion, Nasdaq Executive Vice President and Head of Nasdaq Verafin, emphasized the urgency of industry collaboration in combating fraud. "As criminal threats grow in scale and sophistication, the need for greater industry collaboration has never been more urgent. We are thrilled to partner with BioCatch to further enrich our existing solutions and improve our clients’ ability to fight scams and payments fraud," she said [1].

Gadi Mazor, BioCatch CEO, echoed this sentiment, noting that the partnership will make the job of fraud fighters easier by providing single-screen access to powerful, predictive behavioral and transactional fraud signals. "Our initial integration with Nasdaq Verafin promises to make the job of the fraud fighter immediately easier, giving them single-screen access to powerful, predictive behavioral and transactional fraud signals that enable real-time decisioning across sessions, users, and networks," he said [1].

The partnership also includes additional product integrations, co-developed fraud solutions, and joint research and thought leadership initiatives. Nasdaq Verafin's consortium data network, trusted by over 2,600 financial institutions, provides insights into fraud risk beyond a single institution's view [1]. BioCatch's platform delivers real-time analysis of up to 3,000 unique behavioral and device-related datapoints, allowing banks to differentiate between legitimate and fraudulent transactions [1].

Julie Conroy, Chief Insights Officer at Datos Insights, underscored the significance of the partnership. "This partnership represents a win-win by combining the scale of consortium analytics with the precision of behavioral and device intelligence, enabling a comprehensive defense against increasingly sophisticated fraud attacks," she said [1].

The companies will host a series of webinars in the coming weeks to provide more information on the partnership. For more details, visit [https://verafin.com/nasdaq-verafin-biocatch-partnership](https://verafin.com/nasdaq-verafin-biocatch-partnership) [1].

References:
[1] https://verafin.com/news/nasdaq-verafin-and-biocatch-form-strategic-partnership/